| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7c6f35eb968c4fb96f0f0b8fa6b4ddc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33b011e77b33662b8bf1f2ff2de7b661 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34afd4eacfb216c08278ebdc8af83e71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f00b3addd0bbc187fb4b39c9cda1639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92674ec7827f8bb8182069268f3b896e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31c2b39935b310229ee5296392ceca81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ce2ada3e24e99489e81c89f47cb0120 |
| publicationDate |
2020-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112019013814-A2 |
| titleOfInvention |
method for treating cancer or a tumor in an individual, pharmaceutical composition, combination, and, kit. |
| abstract |
compositions, combinations and methods comprising administering a cdk4 / 6 inhibitor of formula d with a selective estrogen receptor infrarregulator of formula a, b or c which are advantageous for the treatment of abnormal cell proliferation, including cancer or tumor . |
| priorityDate |
2017-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |